Supplier ships advanced magnets

Article

Intermagnetics General has completed, tested, and delivered the first in a series of new 1-tesla open MRI magnets. The new, actively shielded magnet is the centerpiece of Philips’ Panorama 1.0T product, which was introduced as work-in-progress at

Intermagnetics General has completed, tested, and delivered the first in a series of new 1-tesla open MRI magnets. The new, actively shielded magnet is the centerpiece of Philips’ Panorama 1.0T product, which was introduced as work-in-progress at last year’s RSNA meeting. The company has also begun commercial shipments of 3-tesla magnets, which serve as the core of its Intera 3.0T system. The system is designed for high-end neuro, orthopedic, and cardiovascular applications. Despite its very high field strength, Intera 3.0T fits in the same compact casing as lower field Intera systems and has the same 60-cm-diameter bore. Philips’ rising market share and the growth of new applications for 3-tesla scanners has begun to produce incremental revenue, according to Glenn H. Epstein, Intermagnetics president and chief executive officer. The company is looking forward to continued fiscal growth from this product as well as the open 1-tesla system, he said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.